Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · IEX Real-Time Price · USD
7.16
-0.30 (-4.02%)
At close: Jul 2, 2024, 4:00 PM
7.18
+0.02 (0.28%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RXRX stock have an average target of 17.4, with a low estimate of 10 and a high estimate of 33. The average target predicts an increase of 143.02% from the current stock price of 7.16.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RXRX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +137.43% | Jun 25, 2024 |
Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +137.43% | May 10, 2024 |
Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +137.43% | Apr 9, 2024 |
Keybanc | Keybanc | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +123.46% | Mar 4, 2024 |
Needham | Needham | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +137.43% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
60.09M
from 44.58M
Increased by 34.81%
Revenue Next Year
92.26M
from 60.09M
Increased by 53.53%
EPS This Year
-1.71
from -1.58
EPS Next Year
-1.91
from -1.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 87.5M | 267.7M | 218.4M |
Avg | 60.1M | 92.3M | 154.3M |
Low | 44.1M | 43.0M | 92.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 96.2% | 345.4% | 136.7% |
Avg | 34.8% | 53.5% | 67.2% |
Low | -1.1% | -28.4% | 0.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.56 | -1.24 | -1.12 |
Avg | -1.71 | -1.91 | -1.57 |
Low | -1.96 | -3.33 | -1.97 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.